Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx Group (MDXG) EBT Margin: 2011-2025

Historic EBT Margin for Mimedx Group (MDXG) over the last 15 years, with Sep 2025 value amounting to 20.09%.

  • Mimedx Group's EBT Margin rose 651.00% to 20.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 14.16%, marking a year-over-year decrease of 333.00%. This contributed to the annual value of 16.42% for FY2024, which is 689.00% up from last year.
  • According to the latest figures from Q3 2025, Mimedx Group's EBT Margin is 20.09%, which was up 52.31% from 13.19% recorded in Q2 2025.
  • Mimedx Group's EBT Margin's 5-year high stood at 26.62% during Q2 2024, with a 5-year trough of -17.70% in Q1 2022.
  • In the last 3 years, Mimedx Group's EBT Margin had a median value of 13.19% in 2025 and averaged 13.19%.
  • In the last 5 years, Mimedx Group's EBT Margin tumbled by 1,354bps in 2022 and then skyrocketed by 2,745bps in 2023.
  • Quarterly analysis of 5 years shows Mimedx Group's EBT Margin stood at 0.18% in 2021, then spiked by 1,308bps to 13.25% in 2022, then surged by 277bps to 16.02% in 2023, then plummeted by 392bps to 12.11% in 2024, then soared by 651bps to 20.09% in 2025.
  • Its EBT Margin stands at 20.09% for Q3 2025, versus 13.19% for Q2 2025 and 9.76% for Q1 2025.